Skip to Main content Skip to Navigation
Journal articles

Prospects for prostate cancer imaging and therapy using high-affinity TRPM8 activators.

Abstract : One of the best-studied temperature-gated channels is transient receptor potential melastatin 8 (TRPM8), which is activated by cold and cooling agents, such as menthol. Besides inducing a cooling sensation in sensory neurons, TRPM8 channel activation also plays a major role in physiopathology. Indeed, TRPMP8 expression increases in early stages of prostate cancer and its involvement in prostate cell apoptosis has recently been demonstrated. Thus, as TRPM8 is a tumor marker with significant potential use in diagnosis, as well as a target for cancer therapy, there is a need for new TRPM8-specific ligands. In this study, we investigated the action of "WS" compounds on TRPM8 channels. We compared the affinity of these molecules to that of menthol and icilin. This enabled us to identify new TRPM8 agonists. The menthol analog with the highest affinity, WS-12, had an EC(50) value about 2000 times lower than that of menthol and is, therefore, the highest-affinity TRPM8 ligand known to date. Finally, incorporating a fluorine atom in the WS-12 retained 75% of the activity of the parent compound. The high affinity of this new TRPM8 ligand and the possibility of incorporating a radiohalogen could thus be useful for diagnosis, monitoring and, perhaps, even therapy of prostate cancer.
Complete list of metadata

Cited literature [28 references]  Display  Hide  Download
Contributor : Benjamin Beck Connect in order to contact the contributor
Submitted on : Tuesday, March 13, 2007 - 2:23:23 PM
Last modification on : Wednesday, August 24, 2022 - 2:45:01 PM
Long-term archiving on: : Friday, November 25, 2016 - 2:54:28 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document




Benjamin Beck, Gabriel Bidaux, Alexis Bavencoffe, Loic Lemonnier, Stephanie Thebault, et al.. Prospects for prostate cancer imaging and therapy using high-affinity TRPM8 activators.. Cell Calcium, Elsevier, 2007, 41 (3), pp.285-294. ⟨10.1016/j.ceca.2006.07.002⟩. ⟨inserm-00136331⟩



Record views